Bionano Genomics/BNGO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Bionano Genomics

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Ticker

BNGO

Sector

Healthcare

Trading on

NASDAQ

Industry

Scientific & Technical Instr.

CEO

R. Erik Holmlin

Employees

344

Headquarters

San diego, United States

Bionano Genomics Metrics

BasicAdvanced
$65M
Market cap
-
P/E ratio
-$6.15
EPS
2.34
Beta
-
Dividend rate
$65M
2.33793
$8.20
$0.71
1.4M
1.463
1.129
4.319
4.644
-83.42%
-100.76%
-144.33%
-128.31%
1.727
0.673
1.268
26.93%
-29.28%
61.95%

What the Analysts think about Bionano Genomics

Analyst Ratings

Majority rating from 4 analysts.
Buy

Bionano Genomics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-360.91% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$8.7M
-18.69%
Net income
-$31M
-28.31%
Profit margin
-360.91%
-11.83%

Bionano Genomics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 20.93%
QuarterlyAnnual
Q2 23
Q3 23
Q1 24
Q2 24
Actual
-$1.24
-$3.22
-$0.51
-
Expected
-$1.03
-$0.97
-$0.65
-$0.42
Surprise
20.00%
231.96%
-20.93%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bionano Genomics stock?

Bionano Genomics (BNGO) has a market cap of $65M as of June 14, 2024.

What is the P/E ratio for Bionano Genomics stock?

The price to earnings (P/E) ratio for Bionano Genomics (BNGO) stock is 0 as of June 14, 2024.

Does Bionano Genomics stock pay dividends?

No, Bionano Genomics (BNGO) stock does not pay dividends to its shareholders as of June 14, 2024.

When is the next Bionano Genomics dividend payment date?

Bionano Genomics (BNGO) stock does not pay dividends to its shareholders.

What is the beta indicator for Bionano Genomics?

Bionano Genomics (BNGO) has a beta rating of 2.34. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Bionano Genomics stock price target?

The target price for Bionano Genomics (BNGO) stock is $6.33, which is NaN% below the current price of $. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Bionano Genomics stock

Buy or sell Bionano Genomics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing